ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” first quarter ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

Lars Rebien Sørensen, who chairs the Novo Nordisk Foundation, will join its board as an observer while the company seeks a ...

They are large molecule drugs, so complex in structure and must be administered by injection. Importantly, Novo Nordisk's and ... companies invested heavily in manufacturing to increase supply.

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Jørgensen said Novo Nordisk scientists have worked on the weight-loss drugs since the early 1990s. The company also has committed $30 billion to expand manufacturing capacity to address supply ...

as part of new regulations to encourage domestic manufacturing. Novo Nordisk Chief Financial Officer Karsten Munk Knudsen said in an interview it takes years for a pharmaceutical company to build ...

it “wasn't the structure that really allowed us to have data and AI penetrate everything that we do,” Novo Nordisk’s CSO Marcus Schindler, Ph.D., told Fierce Biotech in an interview ahead of ...